Mode of action of Li in treating affective disorders-neurobiological considerations.
D000342:Affective Symptoms / Q000188:drug therapy*; D001921:Brain / Q000187:drug effects; D002462:Cell Membrane / Q000187:drug effects; D004347:Drug Interactions; D006801:Humans; D008094:Lithium / Q000494:pharmacology* / Q000627:therapeutic use; D008606:Mental Processes / Q000187:drug effects; D008959:Models, Neurological; D009043:Motor Activity / Q000187:drug effects; D018377:Neurotransmitter Agents / Q000502:physiology; D011955:Receptors, Drug
D018377:Neurotransmitter Agents; D011955:Receptors, Drug; D008094:Lithium